Organogenesis Holdings Inc. - Common Stock, $0.01 par value (ORGO)

CUSIP: 68621F102

Q1 2026 13F Holders as of 31 Mar 2026

Holder snapshot 7 signals
Share change
-7,647,360
Put/Call ratio
0%
SEC-reported price per share
$2.37
Number of holders
117
Value change
-$27,867,171
Number of buys
46
Open additional details 1 more signal available
Number of sells
88
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
127,085,490

Security key

68621F102

Report period

Q1 2026

Institutions

117

Top holders

10

Ownership snapshot

Top reported holders of ORGO - Organogenesis Holdings Inc. - Common Stock, $0.01 par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Alan A. Ades
Disclosed value leader
Albert Erani Family Trust...
Comparable rows
4/15
Latest evidence
31 Dec 2025
3/4/5 13D/G 13F Lead comparable stake: 18% 11 rows are not safely comparable across share classes. 13D/G row: Alan A. Ades Showing 1-6 of 15 holder rows.

Quick read

Alan A. Ades leads the comparable SEC ownership view at 18%.

4 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Alan A. Ades's linked filing trail.
Comparable ownership Top 4
Alan A. Ades 18%
Glenn H. Nussdorf 9.7%
Soleus Capital Master Fund, L.P. 7.9%
First Light Asset Management, LLC 3.1%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Alan A. Ades
3/4/5 13D/G
Director, 10%+ Owner
18%
Reported 13D/G · 24 Jun 2025
$356,576,106
102,170,804 shares
— 09 Jan 2025
Glenn H. Nussdorf
3/4/5 13D/G
Director
9.7%
Reported 13D/G · 14 May 2025
$64,507,875
11,748,560 shares
-$2,619,180 16 Dec 2025
Soleus Capital Master Fund, L.P.
13D/G
7.9%
Reported 13D/G · 31 Dec 2025
$42,040,854
9,985,951 shares
-$10,520,474 31 Dec 2025
First Light Asset Management, LLC
13F 13D/G
Company · Mathew P. Arens
3.1%
Reported 13D/G · 31 Dec 2025
$20,009,408
3,862,820 shares
— 31 Dec 2025
Albert Erani Family Trust dated 12/29/2012
3/4/5
10%+ Owner
—
denominator unverified
$508,577,870
118,896,054 shares
— 28 Dec 2021
Dennis Erani
3/4/5
10%+ Owner
—
denominator unverified
$508,577,870
118,896,054 shares
— 15 Dec 2021
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2026

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
117
Shares
61,633,029
Rows available
117
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2026 vs Q1 2026 Across Filers

Q1 2026 holders
117
Q1 2026 holders
117
Holder diff
0
Investor Q1 2026 Shares Q1 2026 Shares Share Diff Share Chg % Q1 2026 value Q1 2026 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .